VHAM
TEVA icon

Van Hulzen Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Van Hulzen Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,686
Closed -$1.2M – 88
2014
Q1 		$1.2M Sell
22,686
-3,350
-13% -$155K 1.21% 30
2013
Q4 		$1.04M Buy
+26,036
New +$1.03M 0.9% 41

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Van Hulzen Asset Management's TEVA Position: Q2 2014 in Review

Van Hulzen Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2014, closing a stake of 22,686 shares — an estimated $1.2M sold.

Van Hulzen Asset Management first reported a position in TEVA in Q4 2013 and held it in 2 quarters. The position peaked at $1.2M in Q1 2014. 780 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Van Hulzen Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2014 after selling out during the quarter.
  • Van Hulzen Asset Management sold 22,686 Teva Pharmaceutical Industries Limited shares in Q2 2014, an estimated $1.2M.
  • Van Hulzen Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 2 quarters.
  • Van Hulzen Asset Management's Teva Pharmaceutical Industries Limited position peaked at $1.2M in Q1 2014.
  • 780 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2014.

Based on Van Hulzen Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.